Everything you need to win Element Biosciences — in one platform.
Who to reach, what to say, and why now on Element Biosciences — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Element Biosciences — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
The decision-maker’s email and mobile — dial in-browser.
Element Biosciences raises $175 million in upsized Series E funding led by Samsung Electronics to enhance global growth in genomic solutions.
PRIVATEJun 09, 2026•6 days ago
Amount Raised
$175 Million
Round Type
series e
San DiegoBiotechnologyHealth CareGeneticsLife Science
Investors
Samsung Electronics
Description
Element Biosciences, Inc. announced an upsized Series E round of financing with $175 million from Samsung Electronics. The funding will accelerate commercialization of genomic and multiomic solutions and expand its global presence. This capital will advance development of technologies like AVITI and VITARI
Company Information
Company
Element Biosciences
Location
San Diego, California, United States
About
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. We are developing a modular and high-performing DNA sequencing platform that will deliver high-quality data, increase workflow flexibility, and make next-generation sequencing technology more accessible. Our proprietary approach to improving the signal-to-noise ratio allows us to provide groundbreaking innovations in surface chemistry, instrumentation, and biochemistry to drastically decrease run costs and capital costs while delivering high sequencing data quality.